At Dexcom (Nasdaq:DXCM), one of the leaders in continuous glucose monitoring (CGM), innovation continues to roll on.

Dexcom ONE+ is now available in the UK, incorporating 25 years of Dexcom research to offer a sensor that better meets the needs of those living with diabetes. Dexcom’s first-ever State of Type 2 ...

With a new CEO taking over in 2026, Dexcom aims to stay ahead of its CGM competitors through a combination of innovation and ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, according to the warning letter.

Dexcom has obtained European approval for the latest generation of its wearable diabetes sensor, the G7 continuous glucose monitor, for adults and children ages two and up.

Dive Brief: Dexcom has received clearance for the first over-the-counter (OTC) glucose sensor in the U.S. The Food and Drug Administration cleared the device, Stelo, for use by people 18 years and ...

Oppenheimer downgraded DexCom (DXCM) to Perform from Outperform without a price target after assuming coverage of the name. The company is doing ...

The Dexcom G6 and Abbott FreeStyle Libre are two of the top continuous glucose monitors (CGMs). Each glucose monitor offers different features and has its own pros and cons.